{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:07:18Z","timestamp":1778940438878,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA055695"],"award-info":[{"award-number":["K23DA055695"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA044443"],"award-info":[{"award-number":["R21DA044443"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA050442"],"award-info":[{"award-number":["U01DA050442"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.josat.2024.209538","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:35:48Z","timestamp":1728542148000},"page":"209538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["\u201cYeah, this is not going to work for me\u201d\u2013The impact of federal policy restrictions on methadone continuation upon release from jail or prison"],"prefix":"10.1016","volume":"168","author":[{"given":"Justin","family":"Berk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael-Evans","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiah","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Kaplowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Brinkley-Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.josat.2024.209538_bb0005","article-title":"The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era","volume":"47","author":"Amram","year":"2021","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2024.209538_bb0010","author":"Berk"},{"issue":"9","key":"10.1016\/j.josat.2024.209538_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2024.209538_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.016","article-title":"The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting","volume":"205","author":"Brinkley-Rubinstein","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2024.209538_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-023-00209-w","article-title":"Medications for opioid use disorder during incarceration and post-release outcomes","volume":"11","author":"Cates","year":"2023","journal-title":"Health and Justice"},{"key":"10.1016\/j.josat.2024.209538_bb0030","article-title":"A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder","volume":"2","author":"Cernasev","year":"2021","journal-title":"In Exploratory Research in Clinical and Social Pharmacy"},{"issue":"10","key":"10.1016\/j.josat.2024.209538_bb0035","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2105\/AJPH.2018.304666","article-title":"The first comprehensive program for opioid use disorder in a us statewide correctional system","volume":"108","author":"Clarke","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2024.209538_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104141","article-title":"Typology of laws restricting access to methadone treatment in the United States: A latent class analysis","volume":"119","author":"Conway","year":"2023","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2024.209538_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08897077.2019.1572052","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis","volume":"40","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2024.209538_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/2050324520940428","article-title":"Exploring the impact of the opioid epidemic in Black and Hispanic communities in the United States","volume":"6","author":"Drake","year":"2020","journal-title":"Drug Science, Policy and Law"},{"key":"10.1016\/j.josat.2024.209538_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108746","article-title":"Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail","volume":"138","author":"Evans","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209538_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"\u201cIt\u2019s like \u2018liquid handcuffs\u201d: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10.1016\/j.josat.2024.209538_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/add.15233","article-title":"African Americans now outpace whites in opioid-involved overdose deaths: A comparison of temporal trends from 1999 to 2018","volume":"116","author":"Furr-Holden","year":"2021","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.josat.2024.209538_bb0070","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/add.15293","article-title":"Risk of overdose-related death for people with a history of incarceration","volume":"116","author":"Gan","year":"2021","journal-title":"Addiction"},{"issue":"6408","key":"10.1016\/j.josat.2024.209538_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.josat.2024.209538_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209538_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2024.209538_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/ADM.0000000000001029","article-title":"Anticipated barriers to sustained engagement in treatment with medications for opioid use disorder after release from incarceration","volume":"17","author":"Kaplowitz","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"12","key":"10.1016\/j.josat.2024.209538_bb0095","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2024.209538_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2024.209538_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(23)00023-3","article-title":"Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: Implications for policy","volume":"8","author":"Krawczyk","year":"2023","journal-title":"The Lancet Public Health"},{"key":"10.1016\/j.josat.2024.209538_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103823","article-title":"Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts","volume":"109","author":"Matsumoto","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209538_bb0115","series-title":"New federal rules cannot improve methadone delivery without state actions","author":"McGaffey","year":"2024"},{"key":"10.1016\/j.josat.2024.209538_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108351","article-title":"Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services","volume":"127","author":"Mitchell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209538_bb0125","article-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences Engineering and Medicine","year":"2019"},{"key":"10.1016\/j.josat.2024.209538_bb0130","series-title":"Methadone treatment for opioid use disorder","author":"National Academies of Sciences Engineering and Medicine","year":"2022"},{"issue":"6","key":"10.1016\/j.josat.2024.209538_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/add.15778","article-title":"The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic","volume":"117","author":"Nesoff","year":"2022","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.josat.2024.209538_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.3833","article-title":"Assessment of state and federal health policies for opioid use disorder treatment during the COVID-19 pandemic and beyond","volume":"2","author":"Pessar","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"2","key":"10.1016\/j.josat.2024.209538_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000841","article-title":"Permanent methadone treatment reform needed to combat the opioid crisis and structural racism","volume":"16","author":"Peterkin","year":"2022","journal-title":"In Journal of Addiction Medicine"},{"issue":"9991","key":"10.1016\/j.josat.2024.209538_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.josat.2024.209538_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103803","article-title":"Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers","volume":"110","author":"Stopka","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209538_bb0160","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2024.209538_bb0165","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2024.209538_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209055","article-title":"Tran- sitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder","volume":"150","author":"Thakrar","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209538_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-019-0166-0","article-title":"Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail","volume":"14","author":"Velasquez","year":"2019","journal-title":"Addiction Science and Clinical Practice"},{"issue":"10077","key":"10.1016\/j.josat.2024.209538_bb0180","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(17)30259-3","article-title":"Mass incarceration, public health, and widening inequality in the USA","volume":"389","author":"Wildeman","year":"2017","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.josat.2024.209538_bb0185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.josat.2024.209538_bb0190","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/add.15641","article-title":"Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: Results from a feasibility clinical trial","volume":"117","author":"Wu","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2024.209538_bb0195","doi-asserted-by":"crossref","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:12:14Z","timestamp":1778937134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S2949875924002509"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209538","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cYeah, this is not going to work for me\u201d\u2013The impact of federal policy restrictions on methadone continuation upon release from jail or prison","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209538"}}